ROLE OF THE ENDOCANNABINOID SYSTEM IN THE DEVELOPMENT OF TOLERANCE TO ALCOHOL
Open Access
- 18 November 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 40 (1) , 15-24
- https://doi.org/10.1093/alcalc/agh111
Abstract
The present review evaluates the evidence that the endocannabinoid system plays in the development of tolerance to alcohol. The identification of a G-protein-coupled receptor, namely, the cannabinoid receptor (CB1 receptor), which was activated by Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive component of marijuana, led to the discovery of endogenous cannabinoid agonists. Until now, four fatty acid derivatives identified to be arachidonylethanolamide (AEA), 2-arachidonylglycerol (2-AG), 2-arachidonylglycerol ether (noladin ether) and virodhamine have been isolated from both nervous and peripheral tissues. Both AEA and 2-AG have been shown to mimic the pharmacological and behavioural effects of Δ9-THC. The role of the endocannabinoid system in the development of tolerance to alcohol was not known until recently. Recent studies from our laboratory have implicated for the first time a role for the endocannabinoid system in development of tolerance to alcohol. Chronic alcohol treatment has been shown to down-regulate CB1 receptors and its signal transduction. The observed downregulation of CB1 receptor function results from the persistent stimulation of the receptors by AEA and 2-AG, the synthesis of which has been shown to be increased by chronic alcohol treatment. The enhanced formation of endocannabinoids may subsequently influence the release of neurotransmitters. It was found that the DBA/2 mice, known to avoid alcohol intake, have significantly reduced CB1 receptor function in the brain, consistent with other studies in which the CB1 receptor antagonist SR 141716A has been shown to block voluntary alcohol intake in rodents. Similarly, activation of the CB1 receptor system promoted alcohol craving, suggesting a role for the CB1 receptor gene in excessive alcohol drinking behaviour and development of alcoholism. Ongoing investigations may lead to a better understanding of the mechanisms underlying the development of tolerance to alcohol and to develop therapeutic strategies to treat alcoholism.Keywords
This publication has 95 references indexed in Scilit:
- Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neuronsEuropean Journal of Pharmacology, 2003
- Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overviewProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Cannabinoid receptor agonist‐stimulated [35S]guanosine triphosphateγs binding in the brain of C57BL/6 and DBA/2 miceJournal of Neuroscience Research, 2001
- Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neuronsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerolNeuroReport, 2000
- Chronic Ethanol Increases the Cannabinoid Receptor Agonist Anandamide and Its Precursor N‐Arachidonoylphosphatidylethanolamine in SK ‐ N ‐ SH CellsJournal of Neurochemistry, 1999
- Down-regulation of cannabinoid receptor agonist-stimulated []GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouseBrain Research, 1999
- Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membraneBrain Research, 1998
- Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2Biochemical Pharmacology, 1998
- Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptorsPsychopharmacology, 1997